Joshua T Brumm - Net Worth and Insider Trading

Joshua T Brumm Net Worth

The estimated net worth of Joshua T Brumm is at least $15 Million dollars as of 2024-11-10. Joshua T Brumm is the CEO & President of Dyne Therapeutics Inc and owns about 537,998 shares of Dyne Therapeutics Inc (DYN) stock worth over $15 Million. Joshua T Brumm is also the COO and CFO of Aravive Inc and owns about 33,545 shares of Aravive Inc (ARAV) stock worth over $1,345. Details can be seen in Joshua T Brumm's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joshua T Brumm has not made any transactions after 2024-03-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Joshua T Brumm

To

Joshua T Brumm Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua T Brumm owns 4 companies in total, including Dyne Therapeutics Inc (DYN) , Kaleido Biosciences Inc (KLDO) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of Joshua T Brumm’s form 4 insider trades.

Insider Ownership Summary of Joshua T Brumm

Ticker Comapny Transaction Date Type of Owner
DYN Dyne Therapeutics Inc 2024-03-11 director & See Remarks
KLDO Kaleido Biosciences Inc 2019-02-27 See Remarks
ARAV Aravive Inc 2017-10-19 Chief Financial Officer
LIMIT LIMIT 2012-02-17 VP of Corporate Development

Joshua T Brumm Latest Holdings Summary

Joshua T Brumm currently owns a total of 2 stocks. Among these stocks, Joshua T Brumm owns 537,998 shares of Dyne Therapeutics Inc (DYN) as of March 11, 2024, with a value of $15 Million and a weighting of 99.99%. Joshua T Brumm also owns 33,545 shares of Aravive Inc (ARAV) as of October 19, 2017, with a value of $1,345 and a weighting of 0.01%.

Latest Holdings of Joshua T Brumm

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DYN Dyne Therapeutics Inc 2024-03-11 537,998 28.48 15,322,183
ARAV Aravive Inc 2017-10-19 33,545 0.04 1,345

Holding Weightings of Joshua T Brumm


Joshua T Brumm Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua T Brumm has made a total of 12 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 429,730 shares on March 11, 2024, which brought Joshua T Brumm around $11 Million.

According to the SEC Form 4 filings, Joshua T Brumm has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 221 shares on October 19, 2017, which brought Joshua T Brumm around $3,381.

Insider Trading History of Joshua T Brumm

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua T Brumm Trading Performance

GuruFocus tracks the stock performance after each of Joshua T Brumm's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua T Brumm is -17.12%. GuruFocus also compares Joshua T Brumm's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua T Brumm within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua T Brumm's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua T Brumm

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 16.01 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 17.65 LIMIT LIMIT LIMIT LIMIT LIMIT

Joshua T Brumm Ownership Network

Ownership Network List of Joshua T Brumm

No Data

Ownership Network Relation of Joshua T Brumm

Insider Network Chart

Joshua T Brumm Owned Company Details

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Joshua T Brumm is the director & See Remarks of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Joshua T Brumm made 8 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 1,161,154. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .

In summary, during the past 3 months, insiders sold 1,954,064 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,922,064 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyne Therapeutics Inc Insider Transactions

No Available Data

Joshua T Brumm Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua T Brumm. You might contact Joshua T Brumm via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.